Advertisement
U.S. markets closed

ENDRA Life Sciences Inc. (NDRA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
5.09-0.18 (-3.42%)
At close: 04:00PM EST
5.10 +0.01 (+0.20%)
After hours: 07:57PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.64M
Enterprise Value -1.87M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.40
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.11

Trading Information

Stock Price History

Beta (5Y Monthly) 0.74
52-Week Change 3-99.70%
S&P500 52-Week Change 331.18%
52 Week High 34,882.50
52 Week Low 34.01
50-Day Moving Average 37.53
200-Day Moving Average 3480.82

Share Statistics

Avg Vol (3 month) 3314.9k
Avg Vol (10 day) 3106.8k
Shares Outstanding 5518.28k
Implied Shares Outstanding 6518.28k
Float 841.39k
% Held by Insiders 10.28%
% Held by Institutions 10.49%
Shares Short (Oct 31, 2024) 424.03k
Short Ratio (Oct 31, 2024) 40.05
Short % of Float (Oct 31, 2024) 44.64%
Short % of Shares Outstanding (Oct 31, 2024) 44.64%
Shares Short (prior month Sep 30, 2024) 47.66k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:35
Last Split Date 3Nov 07, 2024

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-60.94%
Return on Equity (ttm)-120.13%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -9.52M
Net Income Avi to Common (ttm)-9.57M
Diluted EPS (ttm)-2,966.92
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)6.4M
Total Cash Per Share (mrq)154.63
Total Debt (mrq)549.13k
Total Debt/Equity (mrq)6.11%
Current Ratio (mrq)4.97
Book Value Per Share (mrq)27.23

Cash Flow Statement

Operating Cash Flow (ttm)-9M
Levered Free Cash Flow (ttm)-2.48M